INVESTIGADOR PRINCIPAL

• GE Healthcare Ltd: Clinical Trial: Open Label, Multicenter, Phase 4 Study to Demonstrate the Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects with Heart Failure who will Experience Death during 60 Months Follow-up (2014)